Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells

This publication has 32 references indexed in Scilit:

• Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
  New England Journal of Medicine, 2009
• Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
  Nature Reviews Cancer, 2009
• The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
  The Oncologist, 2009
• A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
  Cancer Research, 2008
• ERBB receptors and cancer: the complexity of targeted inhibitors
  Nature Reviews Cancer, 2005
• Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level
  Journal of Cellular Physiology, 2003
• The EGFR family and its ligands in human cancer
  European Journal of Cancer, 2001
• ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients
  The American Journal of Surgery, 1992
• Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu
  Journal of Steroid Biochemistry, 1989